perindopril has been researched along with Alveolitis, Fibrosing in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, SX; Cheng, YX; Li, X; Meng, Y; Tong, WC | 1 |
| Housa, D; Matej, R; Olejár, T; Poucková, P; Zadinová, M | 1 |
2 other study(ies) available for perindopril and Alveolitis, Fibrosing
| Article | Year |
|---|---|
[Perindopril and losartan attenuate bleomycin A5-induced pulmonary fibrosis in rats].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Bleomycin; Blotting, Western; Losartan; Male; NF-kappa B; Perindopril; Pulmonary Fibrosis; Random Allocation; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Transforming Growth Factor beta1 | 2008 |
Radiation-induced production of PAR-1 and TGF-beta 1 mRNA in lung of C57Bl6 and C3H murine strains and influence of pharmacoprophylaxis by ACE inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Female; Gamma Rays; Immunoenzyme Techniques; Lung; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Perindopril; Pulmonary Fibrosis; Radiation Injuries, Experimental; Radiation-Protective Agents; Receptor, PAR-1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta | 2007 |